Virus threshold determines disease in SIVsmmPBj14-infected macaques

AIDS Research and Human Retroviruses

Volumn 15, Issue 2, 1999, Pages 183-194

  O'Neil, Shawn P ^a,b   Mossman, Sally P ^a,c   Maul, Donald H ^a   Hoover, Edward A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P27; VIRUS ANTIBODY; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPHATIC TISSUE; LYMPH NODE; MACACA; NONHUMAN; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MACACA NEMESTRINA; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; PROVIRUSES; RETROVIRIDAE PROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD; VIRAL PROTEINS;

EID: 0033585449     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311600     Document Type: Article

References (41)

1. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, and Gupta P: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-579.
2. Hogervorst E, Jurriaans S, de Wolf F, van Wijk A, Wiersma A, Valk M, Roos M, van Gemen B, Coutinho R, Miedema F, and Goudsmit J: Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: Low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 1995;171:811-821.
3. Wong MT, Dolan MJ, Kozlow E, Doe R, Melcher GP, Burke DS, Boswell RN, and Vahey M: Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type-1 infected persons. J Infect Dis 1996;173:877-887.
4. Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L, and the Swiss HIV Cohort Study Group: Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. J Infect Dis 1996;173:1388-1393.
5. Watson A, Ranchalis J, Travis B, McClure J, Sutton W, Johnson PR, Hu S-L, and Haigwood NL: Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival. J Virol 1997;71:284-290.
6. Haigwood NL, Watson A, Sutton WF, McClure J, Lewis A, Ranchalis J, Travis B, Voss G, Letvin NL, Hu S-L, Hirsch VM, and Johnson PR: Passive immune globulin therapy in the SIV/macaque model: Early intervention can alter disease profile. Immunol Lett 1996;51:107-114.
7. Lohman BL, McChesney MB, Miller CJ, McGowan E, Joye SM, Van Rompay KKA, Reay E, Antipa L, Pedersen NC, and Marthas ML: A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol 1994;68:7021-7029.
8. Hirsch VM, Goldstein S, Hynes NA, Elkins WR, London WT, Zack PM, Montefiori D, and Johnson PR: Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. J Infect Dis 1994;170:51-59.
9. Desrosiers RC, Wyand MS, Kodama T, Ringler DJ, Arthur LO, Sehgal PK, Letvin NL, King NW, and Daniel MD: Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci USA 1989;86:6353-6357.
10. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, and Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-1941.
11. Martin LN, Murphey-Corb M, Soike KF, Davison-Fairburn B, and Baskin GB: Effects of initiation of 3′-azido-3′-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J Infect Dis 1993;168:825-835.
12. Fultz PN, McClure HM, Anderson DC, and Switzer WM: Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses 1989;5:397-409.
13. Fultz PN and Zack PM: Unique lentivirus-host interactions: SIVs-mmPBj14 infection of macaques. Virus Res 1994;32:205-225.
14. Israel ZR, Dean GA, Maul DH, O'Neil SP, Dreitz MJ, Mullins JI, Fultz PN, and Hoover EA: Early pathogenesis of disease caused by SIVsmmPBj14 molecular clone 1.9 in macaques. AIDS Res Hum Retroviruses 1993;9:277-286.
15. Lewis MG, Zack PM, Elkins WR, and Jahrling PB: Infection of rhesus and cynomolgous macaques with a rapidly fatal SIV (SIVsmm/PBj) isolate from sooty mangabeys. AIDS Res Hum Retroviruses 1992;8:1631-1639.
16. Fultz PN: Replication of an acutely lethal simian immunodeficiency virus activates and induces proliferation of lymphocytes. J Virol 1991;65:4902-4909.
17. Schwiebert R and Fultz PN: Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: Correlation between in vitro and in vivo events. J Virol 1994;68:5538-5547.
18. Gummuluru S, Novembre FJ, Lewis M, Gelbard HA, and Dewhurst S: Apoptosis correlates with immune activation in intestinal lymphoid tissue from macaques acutely infected by a highly enteropathic simian immunodeficiency virus, SIVsnimPBj14. Virology 1996;225:21-32.
19. O'Neil SP and Hoover EA: SIVsmmPBj14-bcl.3 induces lymphocyte proliferation and widespread apoptosis in lymphoid tissues of pigtailed macaques. In preparation (1999).
20. Schwiebert RS, Tao B, and Fultz PN: Loss of the SIVsmmPBj14 phenotype and nef genotype during long-term survival of macaques infected by mucosal routes. Virology 1997;230:82-92.
21. Novembre JF, Lewis MG, Saucier MM, Yalley-Ogunro J, Brennan T, McKinnon K, Bellah S, and McClure HM: Deletion of the nef gene abrogates the ability of SIVsmmPBj to induce acutely lethal disease in pigtail macaques. AIDS Res Hum Retroviruses 1996;12:727-736.
22. Saucier M, Hodge S, Dewhurst S, Gibson T, Gibson JP, McClure HM, and Novembre FJ: The tyrosine-17 residue of nef in SIVsmmPBj14 is required for acute pathogenesis and contributes to replication in macrophages. Virology 1998;244:261-272.
23. Sasseville VG, Du Z, Chalifoux LV, Pauley DR, Young HL, Sehgal PK, Desrosiers RC, and Lackner AA: Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant of SIVmac239. Am J Pathol 1996;149:163-176.
24. Mossman SP, Bex F, Berglund P, Arthos J, O'Neil SP, Riley D, Maul DH, Bruck C, Momin P, Burny A, Fultz PN, Mullins JI, Liljestrom P, and Hoover EA: Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol 1996;70:1953-1960.
25. Hirsch VM, Zack PM, Vogel AP, and Johnson PR: Simian immunodeficiency virus infection of macaques: End-stage disease is characterized by widespread distribution of proviral DNA in tissues. J Infect Dis 1991;163:976-988.
26. Dewhurst S, Embretson JE, Anderson DC, Mullins JI, and Fultz PN: Sequence analysis and acute pathogenicity of molecularly cloned SIVsmmPBj14. Nature (London) 1990;345:636-640.
27. Birx DL, Lewis MG, Vahey M, Tencer K, Zack PM, Brown CR, Jahrling PB, Tosato G, Burke D, and Redfield R: Association of interleukin-6 in the pathogenesis of acutely fatal SIVsmm/PBj14 in pigtailed macaques. AIDS Res Hum Retroviruses 1993;9:1123-1129.
28. O'Neil SP, Mossman SP, Maul DH, and Hoover EA: In vivo cell and tissue tropism of SIVsmmPBj14-bcl.3. AIDS Res Hum Retroviruses 1999;15:203-215.
29. Chakrabarti L, Isola P, Cumont MC, Claessens-Maire MA, Hurtrel M, Montagnier L, and Hurtrel B: Early stages of simian immunodeficiency virus infection in lymph nodes. Am J Pathol 1994;144:1226-1237.
30. Lackner AA, Vogel P, Ramos RA, Kluge JD, and Marthas M: Early events in tissues during infection with pathogenic (SIVmac239) and non-pathogenic (SIVmac1A11 ) molecular clones of simian immunodeficiency virus. Am J Pathol 1994;145:428-439.
31. Baskin GB, Martin LN, Murphey-Corb M, Hu F, Kuebler D, and Davison B: Distribution of SIV in lymph nodes of serially sacrificed rhesus monkeys. AIDS Res Hum Retroviruses 1995;11;273-285.
32. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ, and Letvin NL: Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994;68:2362-2370.
33. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
34. Ho D, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
35. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
36. Fox CH, Tenner-Racz K, Racz P, Firpo A, Pizzo PA, and Fauci AS: Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. J Infect Dis 1991;164:1051-1057.
37. Pantaleo G, Graziosi C, Butini L, Pizzo PA, Schnittman SM, Kotler DP, and Fauci AS: Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 1991;88:9838-9842.
38. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
39. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
40. Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, and Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
41. Gummuluru S, Novembre FJ, Seshi B, and Dewhurst S: SIVsmmPBj14 induces expression of a mucosal integrin on macaque lymphocytes. Virology 1996;215:97-100.